The coprophilic ascomycete Coniochaeta ellipsoidea DSM 13856 forms the new antibiotic coniosetin (1) in surface cultures grown on a medium containing malt extract and oatmeal. The structure of the compound C25H35NO4, MW 413, was determined by 2D-NMR and mass spectrometric studies. Coniosetin belongs to the class of tetramic acids; it consists of a substituted aliphatic bicyclic ring system linked to a tetramic acid subunit through a carbonyl center. The absolute configuration was determined by measuring its circular dichroism spectrum and comparing the data with those of equisetin. Coniosetin has a pronounced antibacterial and antifungal action, inhibiting even multi drug-resistant strains of negative bacteria.
The coprophilic ascomycete Coniochaeta ellipsoidea DSM 13856 forms the new antibiotic coniosetin (1) in surface cultures grown on a medium containing malt extract and oatmeal. The structure of the compound C25H35NO4, MW 413, was determined by 2D-NMR and mass spectrometric studies. Coniosetin belongs to the class of tetramic acids; it consists of a substituted aliphatic bicyclic ring system linked to a tetramic acid subunit through a carbonyl center. The absolute configuration was determined by measuring its circular dichroism spectrum and comparing the data with those of equisetin. Coniosetin has a pronounced antibacterial and antifungal action, inhibiting even multi drug-resistant strains of negative bacteria.
An obvious consequence of the development of resistance by pathogenic microorganisms1) is a growing demand for new medicines for the control of infectious diseases. However, a review article by J. J. BRONSON and J. F. BARRETT2) has shown that the pharmaceutical industry, no doubt as a result of having abandoned the intensity with which it had conducted antibiotic screenings in earlier decades, is now for the most part working on antibacterial products that are merely variants of known classes of antibiotic. In the course of our investigations into new natural products, we isolated an antibiotic that bore no resemblance to antiinfective agents in current use and embarked on an investigation of the new compound (1). Reports in the scientific literature of secondary metabolites of ascomycetes of the genus Coniochaeta have up to now been few and far between, the only examples being the benzopyranone derivatives coniochaetone A and B3), isolated from C. saccardoi and C. tetraspora, which
show not only antifungal, but also monoamine oxidase inhibiting activity4). This prompted an investigation of constituents of the coprophilic fungus Coniochaeta ellipsoidea Udagawa, DSM 13856, which led to the discovery of a new antibiotic which we named coniosetin
(1). In this article we describe the microbiological production, isolation, structural characterization, and some biological properties of the compound 1.
Materials and Methods

General
Quantitative ultraviolet absorption spectra were recorded using a Perkin Elmer Lambda 2 spectrometer; for all other purposes, including the performance of HPLC analyses, Hewlett-Packard series 1100 equipment fitted with diode array detectors was used. Preparative HPLC was performed 
Isolation
The colonized agar of the surface cultures grown on nutrient medium A was removed from the plates, freeze- 0.5ml of DMSO-d6. Wilmad NMR tubes (grade 528) with a diameter of 5mm were used. All spectra were recorded on a Bruker DRX600 spectrometer operating at 600.13MHz and 150.92MHz for 1H and 13C respectively or on a Bruker DRX500 operating at 500.13MHz (1H) and 125.76MHz (13C). The temperature was set at 300K for all samples. All experiments were performed in phase-sensitive mode using standard pulse sequences employing time-proportional phase incrementation (TPPI) for quadrature detection in F15).
For the homonuclear experiments (double quantumfiltered [DQF]-COSY6-8), NOESY9-10), ROESY11)) the spectral width was set to 7ppm (methanol-d4) or 19ppm (DMSO-d6) in both dimensions, F1 and F2. For all experiments 512 increments in t1 were recorded with 2048 complex data points in t2. Either 8, 24, or 32 transients were averaged for each t1 value. The ROESY spectrum was recorded with a mixing time of 150ms and a B1 field strength of 3kHz. In the NOESY experiment the mixing delay was set to 600ms.
To record heteronuclear multiple quantum correlation (HMQC) spectra12), 512 increments with 16 (DMSO-d6) or 64 scans (methanol-d4) and 2048 complex data points in t2 were collected. Sweep widths of 7ppm in the proton dimension and 160ppm in the carbon dimension were used.
A bilinear rotation decoupling (BIRD) pulse was applied to suppress magnetization of protons bound to 12C. A delay of 3.45ms, corresponding to 145Hz, was used for the evolution of 1H-13C one-bond couplings. The heteronuclear multiple bond correlation (HMBC) spectra13) were acquired with a sweep width of 7ppm (methanol-d4) or 19ppm
(DMSO-d6) in the proton dimension and 220ppm in the carbon dimension. 512 increments in t1 and 2048 complex data points in t2 were recorded. The delay for the evolution of long-range correlations was set to correspond to nJCH coupling constant values of 7Hz. 32 (DMSO-d6) or 64
(methanol-d4) scans per increment were collected. Before undergoing Fourier transformation, all 2D time domain data were subjected to apodization using adjusted sine and squared sine bell window functions. The software packages XWINNMR and AURELIA (Bruker, Rheinstetten, Germany) were used for data processing. 
Antibacterial Activity
Minimal inhibitory concentrations (MIC) were measured by a two-fold microdilution method in Mueller-Hilton broth medium (pH 7.4; Diagnostic Pasteur, France). A standard inoculum of 105 cfu/ml was used. Plates were incubated at concentration at which no visible growth could be detected.
Results
The 
Structure Elucidation by NMR
The structure of coniosetin was determined by NMR studies using a combination of 1D and 2D NMR techniques including 1H, 13C, DQF-COSY, ROESY, NOESY, 1H-13C HMQC, and 1H-13C HMBC spectra. Proton and carbon resonances were assigned using solutions in methanol-d4 and DMSO-d6 (Table 2) .
Coniosetin ( Fig. 1) consists of three structural subunits: a decalin ring system, a tetramic acid moiety and an olefinic side chain. It is a novel isomer of the HIV integrase inhibitor phomasetin16) with different activity.
Comparison of the 1H and 13C chemical shifts of coniosetin with those published for phomasetin indicated that the structures of the decalin ring moiety and olefinic side chain are the same in both compounds. This result was further substantiated by the 1H-13C long range correlations observed in the HMBC spectrum of the coniosetin sample (Fig. 2) . In particular, the connection of the olefinic side chain to position 2 of the decalin ring is proved by the observation of a cross peak between C2 and H12 in the DMSO-d6 and methanol-d4 sample and by a weak fourbond correlation between C11 and 3-CH3 (seen only in methanol-d4). The position of the 3-methyl group was determined from the correlations between C2, C3, C4 and the methyl protons in the HMBC spectrum. 1-CH3 is connected to C1 by 1H-13C J-coupling cross peaks from the methyl protons to C1, C2, C10, and C14. In addition to the 1H -13C correlations shown, the observed cross peaks for the proton spin systems in the DQF-COSY spectrum allowed the assignment of the strech C5-C10 and of the olefinic side chain.
As was evident from the NMR spectra, the structural difference between coniosetin and phomasetin is located in the tetramic acid moiety. Whereas in phomasetin the amide nitrogen (N-17) is methylated and position 18 bears a hydroxymethyl group, in coniosetin N-17 carries a hydrogen and C18 a 1-hydroxyethyl side chain. The amide proton was observed in the 1H NMR spectrum of coniosetin as a broad singlet at 9.22ppm. Signals at 3.91 (13C: 65.66ppm) and 1.17ppm (13C: 20.67ppm) are attributable to the hydroxyethyl side chain. In addition, strong NOE correlations are observed between the amide proton and 21- Whereas the relative configuration of coniosetin thus largely corresponds to that of phomasetin, the specific MeOH) is of the same magnitude and sign as that of quasi-mirror image stereochemical homolog of phomasetin, CHCl3)16). Coniosetin can thus be assigned the absolute configuration of equisetin and not the steric configuration of phomasetin.
To confirm the stereochemistry of coniosetin (Fig. 1) , its CD spectrum was recorded. Fig. 4 Although the past ten years has seen a downturn in classical antibiotic screening reported in the scientific literature, in the same period there has been an astonishingly high number of publications describing naturally occurring tetramic acids with antibiotic activity.
Current understanding of these natural 2, 4-pyrrolidinediones was the subject of a 1995 review by B. J. L. ROYLES17). Others since reported include vancoresmycin18), ascosalipyrrolidinone A19), reutericyclin20), F-1077821), rubrosides22), cryptocin23), talaroconvolutins24), xanthobaccin A25), CJ-17,57226), and CJ-21,05827). This list does not include the new tetramic acids for which effects other than antibiotic activity have been reported. The 2, 4-pyrrolidinedione subunit is thus clearly a common structure type in natural products of microbial or marine origin. The antibiotic coniosetin described here possesses a bicyclic nonpolar ring system and a polar tetramic acid moiety. Its structure resembles that of phomasetin, apart from the unsubstituted ring nitrogen atom in coniosetin.
The relative configuration of the two antibiotics is also the same, though their absolute configurations are mirror images of one another, i.e. coniosetin and phomasetin represent a rare example of a pair of complex natural products with mirror-image stereochemistry. Coniosetin shows strong antibiotic activity against Grampositive bacteria, though its additional inhibitory activity against fungi points to a cytotoxicity similar to that observed for its structural analog equisetin28). The equally high activity of coniosetin toward sensitive and resistant microbial pathogens alike demonstrates that nature is still capable of providing us with highly potent active substances that could overcome current problems with resistance in the treatment of bacterial infections. The very specific conditions under which the new antibiotic coniosetin is formed by the common fungus Coniochaeta ellipsoidea shows, moreover, that microbial cultures represent a source of active agents that is still not remotely exhausted.
